These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 15611238)

  • 1. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.
    Sugiyama H; Gyulai R; Toichi E; Garaczi E; Shimada S; Stevens SR; McCormick TS; Cooper KD
    J Immunol; 2005 Jan; 174(1):164-73. PubMed ID: 15611238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals.
    Cavani A; Nasorri F; Ottaviani C; Sebastiani S; De Pità O; Girolomoni G
    J Immunol; 2003 Dec; 171(11):5760-8. PubMed ID: 14634084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors.
    Hirahara K; Liu L; Clark RA; Yamanaka K; Fuhlbrigge RC; Kupper TS
    J Immunol; 2006 Oct; 177(7):4488-94. PubMed ID: 16982885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus.
    Liang S; Alard P; Zhao Y; Parnell S; Clark SL; Kosiewicz MM
    J Exp Med; 2005 Jan; 201(1):127-37. PubMed ID: 15630140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment.
    Keijsers RR; Joosten I; Hendriks AG; Koenen HJ; van Erp PE; van de Kerkhof PC
    Exp Dermatol; 2015 Jan; 24(1):65-7. PubMed ID: 25355140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin.
    Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC
    Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
    Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
    J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.
    Albert MH; Liu Y; Anasetti C; Yu XZ
    Eur J Immunol; 2005 Sep; 35(9):2598-607. PubMed ID: 16078276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes.
    Venet F; Pachot A; Debard AL; Bohé J; Bienvenu J; Lepape A; Monneret G
    Crit Care Med; 2004 Nov; 32(11):2329-31. PubMed ID: 15640650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia.
    Ruprecht CR; Gattorno M; Ferlito F; Gregorio A; Martini A; Lanzavecchia A; Sallusto F
    J Exp Med; 2005 Jun; 201(11):1793-803. PubMed ID: 15939793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation.
    Earle KE; Tang Q; Zhou X; Liu W; Zhu S; Bonyhadi ML; Bluestone JA
    Clin Immunol; 2005 Apr; 115(1):3-9. PubMed ID: 15870014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity.
    Zhang L; Yang XQ; Cheng J; Hui RS; Gao TW
    Clin Immunol; 2010 Apr; 135(1):108-17. PubMed ID: 20006553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
    Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
    J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells.
    Baecher-Allan C; Wolf E; Hafler DA
    Clin Immunol; 2005 Apr; 115(1):10-8. PubMed ID: 15870015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
    Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
    Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
    Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
    Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
    Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
    J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.